Visterra
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
275 Second Ave Fl 4, Waltham, Massachuse...Phone Number
(617) 498-1070Website
www.visterrainc.comRevenue
$18.9 MillionIndustry
About Visterra
Visterra is a biologics research and early-stage clinical development company focused on creating therapies for patients suffering from immune-mediated and other challenging diseases. The company employs innovative technologies and approaches, including computational, AI, and experimental research methods, to develop novel therapeutics. Visterra aims to make a meaningful impact through collaboration and a high-performing team culture. Their commitment to addressing difficult-to-treat diseases drives their research and development efforts.Explore more
Visterra Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Visterra
Compare insights from companies similar to Visterra, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$105M
201-500
Public
$237.2M
1997
CE
Celia EckertSenior Vice President, General Counsel & Corporate Secretary
Visterra Tech Stack
A closer look at the technologies used by Visterra
Top Business Services Companies
Frequently Asked Questions Regarding Visterra
Sign Up For FreeTo access detailed company insights
Visterra is a biologics research and early-stage clinical development company focused on creating therapies for patients suffering from immune-mediated and other challenging diseases. The company employs innovative technologies and approaches, including computational, AI, and experimental research methods, to develop novel therapeutics. Visterra ai... Read More
